PROCEPT BioRoboticsPRCT +1.16%70 Market Cap is $1,186.8 Mil as of Jun. 25, 2026. GuruFocus rates PRCT with a GF Score™ of 70/100 and a GF Value™ of $91.98 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, PROCEPT BioRobotics ranks better than 81.29% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PROCEPT BioRobotics's share price for the quarter that ended in Mar. 2026 was $25.01. PROCEPT BioRobotics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 56.9 Mil. Therefore, PROCEPT BioRobotics's market cap for the quarter that ended in Mar. 2026 was $1,423.0 Mil.
PROCEPT BioRobotics's quarterly market cap
declined
from Sep. 2025 ($1,994.0 Mil) to Dec. 2025 ($1,771.9 Mil) and
declined
from Dec. 2025 ($1,771.9 Mil) to Mar. 2026 ($1,423.0 Mil).
PROCEPT BioRobotics's annual market cap
increased
from Dec. 2023 ($2,127.8 Mil) to Dec. 2024 ($4,405.9 Mil) but then
declined
from Dec. 2024 ($4,405.9 Mil) to Dec. 2025 ($1,771.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PROCEPT BioRobotics's Enterprise Value for Today is $1,019.1 Mil.
PROCEPT BioRobotics (NAS:PRCT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PROCEPT BioRobotics Market Cap Related Terms
PROCEPT BioRobotics Market Cap Historical Data
* Premium members only.
The historical data trend for PROCEPT BioRobotics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PROCEPT BioRobotics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PROCEPT BioRobotics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Market Cap distribution charts can be found below:
* The bar in red indicates where PROCEPT BioRobotics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PROCEPT BioRobotics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PROCEPT BioRobotics (PRCT) has a Market Cap of $1,186.8 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PROCEPT BioRobotics and its competitors. According to the industry distribution chart, PROCEPT BioRobotics ranks #162 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 18.7%.
Is PROCEPT BioRobotics' Market Cap too high?
PROCEPT BioRobotics' current Market Cap is $1,186.8 Mil. The Medical Devices & Instruments industry median Market Cap is 122.09. PROCEPT BioRobotics' value of $1,186.8 Mil is 872% above this industry median. Based on the distribution chart, PROCEPT BioRobotics ranks #162 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PROCEPT BioRobotics has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Market Cap compare to ALMR and AHCO?
According to the Medical Devices & Instruments industry distribution chart, PROCEPT BioRobotics ranks #162 out of 866 companies for Market Cap. This places PROCEPT BioRobotics in the top 19% of its industry — outperforming the majority of peers. The industry median Market Cap is 122.09. PROCEPT BioRobotics' value of $1,186.8 Mil is 872% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.09, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PROCEPT BioRobotics's current Market Cap of $1,186.8 Mil is 872% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PROCEPT BioRobotics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PROCEPT BioRobotics's current Market Cap is $1,186.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is $91.98, compared to a current price of $20.85 — trading 77.3% below its estimated fair value. The current Market Cap is $1,186.8 Mil and 872% above the Medical Devices & Instruments industry median of 122.09. PROCEPT BioRobotics' overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PROCEPT BioRobotics (PRCT), the current Market Cap is $1,186.8 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PROCEPT BioRobotics (PRCT) Overvalued in 2026?
Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued.
The current stock price of $20.85 is trading 77.3% below its estimated GF Value™ of $91.98.
GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.
Key valuation signals for PRCT:
Market Cap: $1,186.8 Mil
GF Value™: $91.98 vs. price of $20.85 (77.3% below fair value)
Industry Position: 872% above the Medical Devices & Instruments median (#162 of 866)
No single metric tells the full story. See the PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
70GF Score
Get the complete analysis for PRCT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRCT has been successfully added to your 
